Alex Goldberg

NASDAQ Gainers Watch List: priceline.com Incorporated (NASDAQ:PCLN) and Amgen Inc. (NASDAQ:AMGN) Added to Equity Profile Report's NASDAQ Gainers Watch List.

 
Repost This

Wilmington, DE -- (SBWIRE) -- 02/07/2014 -- Equity Profile Report expands its NASDAQ Gainers Weekly Watch List adding priceline.com Incorporated (NASDAQ:PCLN) and Amgen Inc. (NASDAQ:AMGN).

priceline.com Incorporated (NASDAQ:PCLN) operates as an online travel company is currently up (+4.42%) on 893,465 shares traded after Priceline.com Announced to Webcast 4th Quarter and Full-Year 2013 Financial Results on February 20, 2014. priceline.com Incorporated (NASDAQ:PCLN) is currently up (+77.92%) from its recent 52-week low which has prompted Equity Profile Report to add the stock to their NASDAQ Gainers Watch List.

Click Here to find out what other Investors are saying about priceline.com Incorporated (NASDAQ:PCLN)

Amgen Inc. (NASDAQ:AMGN) a biotechnology medicines company that engages in the discovery, development, manufacture, and marketing of human therapeutic products in the areas of supportive cancer care, inflammation, nephrology, and bone diseases primarily in the United States, Europe, and Canada is currently up (+2.33%) on 1,682,146 shares traded after Amgen And Merck Announced Collaboration To Evaluate Investigational Combination Treatment For Advanced Melanoma. Amgen Inc. (NASDAQ:AMGN) is currently up (+42.8%) from its recent 52-week low which has prompted Equity Profile Report to add the stock to their NASDAQ Gainers Watch List.

Click Here to find out what other Investors are saying about Amgen Inc. (NASDAQ:AMGN)

Equityprofilereport.com monitors and scans the markets for stock related signals as well as any external factors that might bring trading opportunities.

Through a vast network of IR professionals Equityprofilereport.com is often aware of several large investor awareness campaigns being deployed.

Timing is important when trading Small Caps and Penny Stocks.

Simply sign up for free and start receiving exclusive alerts.

Subscribe Here: http://www.Equityprofilereport.com

Disclosure
Equityprofilereport.com is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell securities. Investors should always conduct their own due diligence with any potential investment. Please visit Equityprofilereport.com website, for complete risks and disclosures.

Contact Info:
Equity Profile Report
editor@Equityprofilereport.com